Vildagliptin And Metformin Hcl Tablets
Vildagliptin and Metformin HCl Tablets are a combination oral medication used for the effective management of type 2 diabetes mellitus. Metformin works by reducing glucose production in the liver and improving insulin sensitivity, while vildagliptin helps increase insulin release and decrease glucagon levels in a glucose-dependent manner. Together, they provide better and more balanced blood sugar control.
This combination is commonly prescribed when metformin alone is not sufficient to manage blood glucose levels. It helps control both fasting and post-meal blood sugar, supports improved glycemic stability, and reduces the risk of diabetes-related complications. When used along with a healthy diet and regular exercise, it contributes to improved overall diabetes management.
Vildagliptin and Metformin HCL Tablets are a combination medicine used for the effective management of type 2 diabetes mellitus. This dual-therapy formulation brings together two well-established anti-diabetic agents that work in different ways to help control blood sugar levels. It is commonly prescribed when lifestyle changes or single-drug therapy alone are not sufficient to maintain optimal glucose control.
Metformin Hydrochloride works by reducing the production of glucose in the liver and improving the body’s sensitivity to insulin. This allows the cells to use glucose more efficiently and helps lower fasting blood sugar levels. Vildagliptin, a DPP-4 inhibitor, increases the levels of incretin hormones in the body, which stimulate insulin release after meals and suppress excess glucagon secretion. Together, they help regulate blood sugar in a balanced and sustained manner.
This combination is particularly beneficial for patients who experience both high fasting glucose and post-meal blood sugar spikes. By targeting multiple mechanisms involved in glucose regulation, it provides better overall glycemic control compared to single-drug treatment. It also helps reduce the risk of long-term complications associated with uncontrolled diabetes, such as nerve damage, kidney problems, and cardiovascular diseases.
Vildagliptin and Metformin HCL Tablets are usually taken once or twice daily with meals, as directed by a healthcare professional. The tablet form is convenient and easy to incorporate into daily routines, supporting long-term treatment adherence. One of the advantages of this combination is that it generally does not cause weight gain and has a low risk of hypoglycemia when used appropriately.
